Close Menu


Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Type $ Amount Activitysort descending Investigator Unit Sponsor Date
A Phase 3, Randomized, Double- Blinded, Placebo-Controlled Trial To Evaluate the Efficacy and Safety of a Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Infants Born to.... Contract $124,499.00 Clinical Trial Mohamed Ahmed Pediatrics Pfizer, Incorporated 05/2020
A Phase 2a, Multicenter, Open-Label Study of DKN-01 in Combination with Tislelizumab +/- Chemotherapy as First-Line or Second-Line Therapy in Adult Patients with Inoperable, Locally Advanced or Metas Contract $404,272.70 Clinical Trial Aaron Scott Cancer Center Division Leap Therapeutics, Inc. 10/2020
Advancing Liver Therapeutic Approaches (ALTA). The ALTA Consortium Study Group for the management of portal hypertension - A 5-year longitudinal observation study of patients with cirrhosis .... Contract $26,687.50 Clinical Trial Michael Fallon COM Phx Internal Medicine Northwestern University 06/2020
A Phase III Multicenter Open-Label Randomized Trial to Evaluate Efficacy and Safety of FOLFIRINOX (FFX) versus Combination of CPI-613 with modified FOLFIRINOX (mFFX) in Patients with Metastatic... Contract $297,912.00 Clinical Trial Rachna Shroff Cancer Center Division Covance, Incorporated 05/2020
A Phase 1 Open-Label, Multicenter Study to Evaluate Biomarkers for ZN-c5 in Subjects with Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Contract $91,617.50 Clinical Trial Pavani Chalasani Cancer Center Division Zeno Pharmaceuticals, Inc. 01/2020
A Phase 3, Randomized, Double-Blind Study of Adjuvant Immunotherapy with Nivolumab versus Placebo after Complete Resection of Stage IIB/C Melanoma Contract $265,397.00 Clinical Trial Montaser Shaheen Cancer Center Division Bristol-Myers Squibb 10/2020
Expanded Access Program Basis for the Treatment of Relapsed/Refractory Multiple Myeloma Contract $95,540.64 Clinical Trial Krisstina Gowin Cancer Center Division Glaxosmithkline 06/2020
A Randomized, Phase 3 Study of Eryaspase in Combination with Chemotherapy versus Chemotherapy Alone as Second-Line Treatment in Patients with Pancreatic Adenocarcinoma (TRYbeCA-1 - TRial of ErYaspase Contract $664,687.53 Clinical Trial Hani Babiker Cancer Center Division PPD Investigator Services, LLC. 05/2020
A Phase 1, Open-label Study of ASP9801, an Oncolytic Virus, Administered by Intratumoral Injection in Patients with Advanced/Metastatic Solid Tumors Contract $458,027.74 Clinical Trial Hani Babiker Cancer Center Division Parexel International Corporation 01/2020
A Phase I Study of NBTXR3 Activated by Radiotherapy for Patients with Advanced Cancers Treated With An Anti-PD1 Therapy Contract $220,879.50 Clinical Trial Montaser Shaheen Cancer Center Division Nanobiotix (France) 10/2020
PRECISE: Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization Contract $54,987.52 Clinical Trial Michael Morris COM Phx Radiology HeartFlow, Inc. 06/2020
A Randomized, Placebo-Controlled, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of the Subcutaneous Injection of CT-P13 (CT-P13 SC) as Maintenance Therapy in Patients With Moderately Contract $395,132.40 Clinical Trial Sasha Taleban Medicine PPD Investigator Services, LLC. 05/2020
A Phase 2, Double-Blind, Placebo-Controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Relationships of Different Doses.... Contract $273,767.50 Clinical Trial Cori Daines Asthma/Airway Disease Rsch Ctr Janssen Research & Development, LLC 01/2020
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome (ARDS.. Contract $168,927.92 Clinical Trial Marilyn Glassberg Csete COM Phx Internal Medicine Kinevant Sciences, Inc. 08/2020
A Phase Ib/II Study of Leronlimab (PRO 140) Combined with Carboplatin in Patients with CCR5+ Metastatic Triple-Negative Breast Cancer (mTNBC) Contract $122,212.50 Clinical Trial Sima Ehsani Chimeh Cancer Center Division CytoDyn Inc. 10/2020
Total Shoulder Arthroplasty Multi-Center Registry Contract $603,643.00 Clinical Trial Joshua Hustedt COM Phx Orthopedics Arthrex, Incorporated 06/2020
Disease Morphology Image Study Protocol: A Retrospective, Multicenter, Data collection study for information about the disease morphology and stent restenosis patterns in the Iliac and SFA arteries, w Contract $17,187.52 Clinical Trial Kresimira Milas Surgery Bard Peripheral Vascular, Inc. 05/2020
A Phase 2, Multi-Center, Open-Label Study to Evaluate Long-term Safety and Efficacy of CXA-10 in Subjects with Pulmonary Arterial Hypertension on Stable Background Therapy: Extension to Study CXA-10-3 Contract $80,418.76 Clinical Trial Franz Rischard Medicine Complexa, Inc. 01/2020
A Master Protocol to Test the Impact of Discontinuing Chronic Therapies in People with Cystic Fibrosis on Highly Effective CFTR Modulator Therapy (SIMPLIFY) Contract $34,865.00 Clinical Trial Cori Daines Asthma/Airway Disease Rsch Ctr Seattle Children's Hospital 11/2020
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects with Idiopathic Pulmonary Fibrosis (IPF) Contract $607,532.16 Clinical Trial Sachin Chaudhary Medicine Covance, Incorporated 08/2020
COG NCTN Network Group Operations Center Contract $750,000.00 Clinical Trial Holly Pariury Cancer Center Division Children's Hospital of Philadelphia 10/2020
Zephyr Valve Registry (ZEVR) Contract $148,825.60 Clinical Trial Raed Alalawi COM Phx Internal Medicine Pulmonx Corporation 06/2020
Phase 1 Study of VE800 and Nivolumab in Patients with Selected Types of Advanced or Metastatic Cancer Contract $323,394.75 Clinical Trial Hani Babiker Cancer Center Division Vedanta Biosciences, Inc. 05/2020
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate The Efficacy and Safety of Anamorelin HCL for the Treatment OF Malignancy Associated Weight Loss and Anorexia... Contract $42,626.00 Clinical Trial Charles Hsu Cancer Center Division PSI Pharma Support America, Incorporated 01/2020
A Multicenter, Double-Blind, RanDomized, Placebo-Controlled, Parallel-Group Study to determine the EffIcacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects with Fabry Disease Contract $85,957.00 Clinical Trial Christina Laukaitis Medicine Idorsia Pharmaceutical (Switzerland) 11/2020